Premium
Racial differences in nonalcoholic fatty liver disease in the U.S. population
Author(s) -
Schneider Andrea L. C.,
Lazo Mariana,
Selvin Elizabeth,
Clark Jeanne M.
Publication year - 2014
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1002/oby.20426
Subject(s) - nonalcoholic fatty liver disease , medicine , fatty liver , population , disease , environmental health
Objective To characterize the prevalence of nonalcoholic fatty liver disease (NAFLD) by race in a nationally representative sample of the U.S. population and to investigate potential explanatory factors for racial disparities. Design and Methods Cross‐sectional study of 4,037 non‐Hispanic white, 2,746 non‐Hispanic black, and 2,892 Mexican‐American adults in the Third National Health and Nutrition Examination Survey. NAFLD was defined using ultrasound and with elevated aminotransferases. Results Age‐adjusted prevalence of NAFLD was highest in Mexican‐Americans (21.2%), followed by non‐Hispanic whites (12.5%), and was lowest in non‐Hispanic blacks (11.6%). Even after adjustment for demographic, lifestyle, adiposity, and metabolic factors, compared to non‐Hispanic whites, Mexican‐Americans were more likely to have NAFLD (OR: 1.67, 95% CI: 1.26, 2.22). Non‐Hispanic blacks were significantly less likely to have NAFLD with elevated aminotransferases (OR: 0.51, 95% CI: 0.27, 0.97). Racial differences were attenuated among those with normal BMI and among “never drinkers.” Conclusion In this representative sample of the U.S. population, we found significant racial differences in the prevalence of ultrasound‐defined NAFLD (with and without elevated liver enzymes). The racial differences were not fully explained by lifestyle, adiposity, and metabolic factors. More works is needed to identify potential contributors.